Prostasomes, prostatic secretory vesicles found in human ejaculates, were analyzed to verify the existence at their surfaces of enzymes involved in the degradation of the extracellular matrix. Findings were compared with those of prostasomes isolated from two human adenocarcinoma cell lines that reflect clinical features and molecular pathways of androgen-insensitive and hormone-responsive prostate cancer. Our aim was to determine whether neoplastic transformation is accompanied by changes of glycosidase and protease activities. Our results show that decreases of dipeptidyl peptidase IV and increases of urokinase plasminogen activator and cathepsin B are consistent with the clinical features of the cell lines, whereas increases of glycosidase activities seem to be of scarce biological significance.
Introduction
The human prostate gland has a remarkably high incidence of neoplastic disease and prostate cancer is one of the most commonly detected male cancers that result in a high incidence of mortality. At present, prostate cancer is an enormous medical and socioeconomic problem that is going to worsen because of the aging of the population. 1 Prostasomes are present in human seminal plasma as prostate secretory vesicles, and an ordinary exocytotic event involving the fusion of the membranes that surround the storage vesicle and the prostatic secretory cell is the probable mechanism by which they are released. Discovered more than 20 years ago by Ronquist and Brody, 2 they are now biochemically well characterized. Prostasomes are membrane-surrounded organelles with an unusual membrane lipid composition and a striking cholesterol/phospholipid ratio. They contain a large amount of sphingomyelin and a small amount of polyunsaturated phosphatidyl-choline. These characteristics and the presence of saturated and monounsaturated fatty acids make the prostasome membrane highly ordered and rigid. 1 A proteomic analysis has shown the existence at the prostasome surface of at least 139 proteins including enzymes (35%), transport/structural proteins (19%), GTP proteins(14%), chaperone proteins (6%), signal transduction proteins (17%) and novel proteins (9%). 3 Some of these components have already been shown in the prostasomes. 1 Dipeptidyl peptidase IV (DPPIV), which has an extremely high specific activity in prostasomes, 4 has been identified as the antigen of a monoclonal antiprostasome antibody, that is, mAb 78. 5 In prostatic cancer tissues, there is an increased activity of DPPIV that may influence the metabolism and encourage cancer growth, 6 and in the highly invasive 1-LN human prostate tumor cell line, DPPIV is connected with the activation of plasminogen and the expression of matrix metalloproteinase (MMP)-9 7 followed by the degradation of extracellular matrix components and cancer invasion. The invasive behavior of prostate cancer involves the increased expression of enzymes that can decompose parts of the extracellular matrix, thus permitting passage of malignant cells through basement membranes and stromal barriers. Among these enzymes, glycosidases, 8 cathepsin B, 9 plasminogen activator (PA) and MMPs play important roles. 10 Malignant cells depend on these enzymes to disrupt basement membranes, invade neighboring tissues and metastasize to different organs. Since cells either of benign prostate tissue or of prostate carcinoma show similarities in synthesis, storage and release of prostasomes, 11, 12 it is possible that several prostasomal properties, although mainly involved in assisting the fertilization of sperm cells, can also promote the transition from a normal to a neoplastic cell and help the neoplastic prostate cells to survive as metastases, although it has recently been shown that prostasomes inhibit in vivo angiogenesis. 13 Human prostate cancer cell lines also express a granular secretion with properties similar to prostasomes.
11
Both PC3 cells, a line that reflects critical features and common molecular pathways of clinical androgen-insensitive prostate cancer, and LNCaP cells, a line that represents the hormone-responsive tumor model, contain prostasome-like organelles. Although prostasomes are the secretory product of the normal prostate gland, of prostate cancer of different grading and of human prostate cancer cell lines, and although it has recently been hypothesized that lysosomal and prostasomal hydrolytic enzymes and redox processes can initiate prostate cancer, 14 so far no studies have been carried out to investigate whether enzymes involved in the degradation of the extracellular matrix are associated with these organules. In this study, we have shown the presence of such activities on prostasomes from healthy donors and compared the findings with those obtained with prostasomes isolated from PC3 and LNCaP cell lines to find out whether neoplastic transformation is followed by enzyme activity changes at the surface of prostasomes.
Materials and methods

Materials
Ejaculates were obtained after a 3-day abstinence from healthy donors. The parental prostate carcinoma cell lines PC3 and LNCaP were purchased from American Type Culture Collection (ATCC, Manasas, VA, USA) and were cultured in RPMI medium (GIBCO, Grand Island, NY, USA) supplemented with 10% fetal bovine serum and 1% penicillin/streptomycin. Cells were maintained in 5% humidified CO 2 chamber, subculture 1:6 split once per week by trypsinization. In each experiment, cells were seeded at 7.8 Â 10 3 /cm 2 .
Prostasome preparation
Prostasomes were isolated from pooled ejaculates according to conventional procedure. 2 Prostasomes from PC3 and LNCaP cell cultures were obtained by following the conventional procedure with slight modifications. Briefly, cells were recovered at confluence with 0.25% trypsin-EDTA, washed with 30 mM Tris-HCl, 130 mM NaCl, pH 7.6 and stored at À801. Then, cells were thawed, sonicated (10-10 s bursts, 5 s intervals) with Virsonic 60 (Virtis Co., Gardiner, NY, USA) and centrifuged at 1500 g for 30 min and at 6000 g for 20 min to remove cell debris. The supernatant was then conventionally treated. 2 Protein concentration was determined by the Bio-Rad Protein Assay kit (Bio-Rad Lab, Hercules, CA, USA). Unless otherwise stated, all the reagents were purchased from Sigma (St Louis, MO, USA).
Peptidoglycan hydrolyzing enzyme assays
1.25) were measured according to Costanzi et al 15 using the appropriate fluorigenic substrates at concentrations of 1 mM for N-acetyl-b-D-hexosaminidase and 3 mM for the other enzymes. Intensity of fluorescence was measured at 446 nm (excitation at 360 nm). The concentration of product was obtained by reference to a solution of 4-methyl-umbelliferone. For all enzyme activities assayed under these conditions, total substrate hydrolysis was always below 5%. In all measurements, blank substrates and blank samples were used, and all determinations were made in duplicate. One milliunit of activity is the amount of enzyme that hydrolyzes 1 nmol of substrate per minute at 371C. All activities (mU/ml) were normalized to protein concentration (mg/ ml) of the sample used.
Proteolytic enzyme assays
DPPIV (E.C.3.4.14.5) activity was assayed using GlyPro-p-NA as substrate as already described. 16 Cathepsin B (E.C.3.4.22.1) activity and PA (E.C.3.4.21. 68/73) activities were measured according to Aisa et al 17 using Z-Arg-Arg-NH-Mec (Bachem, Switzerland) and ZGly-Gly-Arg-MEC (Bachem, Switzerland), as specific synthetic substrates. Proform of cathepsin B, activated in vitro by treatment with pepsin, 18 was determined after a 60 min incubation at 371C with 20 mg/ml pepsin in 50 mM sodium formiate, pH 3.0, as latent activity that represents the difference between native activity measured in the absence of activation and the total activity measured subsequent to activation with pepsin. In preliminary experiments, pepsin did not hydrolize the synthetic substrate under the above-mentioned assay conditions. Fluorescence was measured at an excitation wavelength of 370 nm and an emission wavelength of 460 nm for cathepsin B activity and at an excitation wavelength of 383 nm and an emission wavelength of 455 nm for PA activity. Bz Arg-NH 2 HCl, a competitive inhibitor of urokinase plasminogen activator (uPA), was used at 6 mM to distinguish between tPA and uPA. The product concentration was obtained by reference to a solution of 7-amino-4-methylcoumarin.
Metalloproteinase (E.C.3.4.24.7) activity was assayed with Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH 2 according to Knight et al. 19 The intensity of fluorescence was measured at 393 nm (excitation at 328 nm). The concentration of the product was obtained by using a solution of MCA-NH 2 as reference. Substrates and standards of tested proteinases were from Bachem (Switzerland).
For all enzyme activities assayed under these conditions, total substrate hydrolysis was always below 5%. One milliunit of activity was defined as the amount of enzyme that releases 1 nmol of product per hour under Prostasome glycosidases and proteases I Bellezza et al specified conditions. In all measurements, blank substrates and blank samples were used, and all determinations were made in duplicate. All activities (mU/ml) were normalized to protein concentration (mg/ml) of the sample used.
Statistical analysis
All results were confirmed in at least five separate experiments and expressed as mean7s.d. Data were analyzed for statistical significance by Student's t-test. Pvalues of less than 0.05 were considered significant.
Results and discussion
To verify whether prostasomes present at their surface enzymes involved in the degradation of the extracellular matrix components and whether the same enzymes are present in prostasomes extracted from PC3 and LNCaP cell lines, we analyzed a series of enzymes involved in the degradation of the glycanic and protein components of the extracellular matrix.
Peptidoglycan hydrolyzing enzymes are glycoproteins located primarily in lysosomes, but also in extracellular fluids such as serum, urine and synovial and cerebrospinal fluid. These enzymes undergo cotranslational glycosylation on selected asparagine residues in the endoplasmic reticulum and achieve compartmentalization through binding of their phosphomannosyl moiety to the phosphomannosyl receptor and translocation of the enzyme-receptor complex to the lysosome. 20 These enzymes have also been found at the surface of human spermatozoa, and increasing evidence indicates a role for sperm glycosidases in mammalian fertilization: a-mannosidase has been associated with the binding of spermatozoa to eggs, b-galactosidase has been implicated in sperm maturation during epididymal transit, and a-N-acetylglucosaminidase has been shown to play a role in the penetration of egg coats. 21 Although these peptidoglycan hydrolyzing activities are involved in many physiological and pathological processes, 14 studies to verify their presence at the surface of human prostasomes have not been carried out and, to our knowledge, this is the first report showing the presence of these enzymes at the prostasome membranes (Table 1) . Prostasomes from healthy ejaculates are characterized by glycan hydrolyzing activities that appear significantly modified in prostasomes extracted from human cancer cell lines. All the specific activities were increased. bHexosaminidase was approximately 3-and 12-fold higher in prostasomes extracted from the PC3 and LNCaP than in prostasomes from healthy ejaculates. bGalactosidase specific activity, although significantly altered compared to the control, was slightly modified in LNCaP, whereas it was increased 10-fold in PC3 cell line. a-Mannosidase was significantly increased in cancer prostasomes by a factor ranging between 200 and 320-fold, whereas b-mannosidase activity was increased 20-fold in LNCaP and not significantly modified in PC3.
Whether these results can be attributed either to an enrichement of the enzymes at the surface of neoplasiaderived prostasomes or to a higher enzyme activity is still unclear. It has been reported that membranes of tumor cells undergo modifications of membrane fluidity 22 and that modifications of membrane fluidity can alter the activity of enzymes localized in distinct membrane microdomains. 23 Therefore, it may be plausible to suggest that prostasomes derived from neoplastic cell lines have a modified fluidity that could be responsible for the observed specific activity variations. On the other hand, since the granular secretions of human prostate cancer cell lines are likely to reflect features and common molecular pathways of clinical androgen-independent and androgen-sensitive prostate cancer, they may reflect cellular properties that promote the transition from a normal to a neoplastic cell and help the neoplastic prostate cells to survive as metastases. However, we think that the reported variations cannot be regarded as prostate cancer hallmarks. If these enzymes reflected the invasive and aggressive behavior of prostate cancer, the highest specific activities of the enzymes degrading the peptidoglycan components of the extracellular matrix should have been found in PC3 cells.
Major biological significance can be attributed to results of proteolytic enzymes involved in the degradation of the protein component of the extracellular matrix ( Table 2) .
We have found that normal prostasomes, that is, isolated from ejaculates of healthy donors, present proteolytic enzymes at their surfaces and that these activities are significantly modified in protasomes isolated from prostate cancer cell lines.
Cathepsin B is a lysosomal cysteine protease that, under normal conditions, participates in the early and late stages of protein degradation. Its role in the process of cancer invasion and metastasis has been under discussion for more than 10 y, and it is still unclear whether increased cathepsin B activity in body tissues and liquids could be used as a biochemical marker of tumor progression. 9 The fact that cathepsin B membrane Prostasome glycosidases and proteases I Bellezza et al activity has been detected in metastatic melanoma and colon cancer cells and that the inhibition of extracellular activity by oral administration of a soluble selective enzyme inhibitor causes significant reduction in the number and dimension of colon cancer metastases in rat liver lobes 24 seems to confirm the participation of this enzyme in the process of metastasis. On the contrary, there are reports in which cathepsin B activity was found unchanged in tumors compared to non-tumor tissues and increased serum cathepsin B activity was found in patients without neoplastic diseases. Some reports do not show a clear correlation between carcinoma progression and cathepsin B. 25 Nevertheless, the marked increase of cathepsin B specific activity that we have found in prostasomes derived from prostate cancer cell lines indicates that higher levels of cathepsin B activity characterize prostatic neoplastic cells. It is also to note that some cancer cells are able to produce the proenzyme, procathepsin B. 26 Our results show that procathepsin B is significantly increased in both cell lines compared to normal prostasomes, and that, after pepsin activation, cathepsin B activity is significantly increased in PC3 compared to LNCaP cell lines.
DPPIV is a multifunctional cell surface protein that, as well as having dipeptidase activity, is the major binding protein for adenosine deaminase and binds extracellular matrix proteins such as fibronectin and collagen. 16, 27 This serine protease, aberrantly expressed in many cancers, functions as a tumor suppressor by regulating the activities of mitogenic peptides implied in cancer development and its decreased expression has been linked to increases in invasion and metastasis. Progression of benign prostate cancer to malignant metastasis is linked to increased production of basic fibroblast growth factor (bFGF), a powerful mitogen whose signaling pathway can be blocked by DPPIV thus inhibiting the malignant phenotype of prostate cancer cells. 28 Our results show a remarkable reduction of DPPIV activity, more marked in PC3. These findings are in agreement with the tumor-suppressing function of this enzyme. They are also in agreement with data from literature showing that PA and MMPs are involved in the proteolytic degradation of extracellular matrix components. 29 We have found increased activities of PA and MMPs in cancer cell-derived prostasomes. In normal tissue, these enzymes are highly regulated, whereas they are upregulated in cancer cells, in particular prostate cancer cells, by a mechanism that is as yet unknown. Significant increases in active MMP-2 are associated with malignant progression of prostate cancer and its metastasis to the lymph nodes. 30 Therefore, the increases in MMPs activity in cancer cell prostasomes was expected although further investigations will be needed to define the MMP types. The ability of a cell to modify the extracellular matrix is important in tumorigenesis and cell transformation is accompanied by changes in the surrounding stroma as a result of the action of specific proteases such as uPA, which has been associated with invasive potential in many tumor types. 31 It has already been reported that membrane vesicles shed by PC3 cells have uPA, an enzyme activity that can promote tumor invasion. 32 In this study, we have analyzed the variation of PA and uPA at the surface of prostasomes isolated from PC3 and LNCaP and compared these findings with those of ejaculated prostasomes. We have found an elevation of PA activity that ranges between 20-and 30-fold, the highest increase found in PC3-derived prostasomes. In ejaculated prostasomes, uPA represents about 10% of the total PA, whereas it rises to approximately 30% in PC3 and LNCaP. uPA has been shown to correlate with human prostate cancer metastasis and an elevated concentration of uPA is a strong indicator of poor prognosis. uPA and its receptor (u-PAR) contribute to prostate cancer metastases by promoting extracellular matrix degradation and growth factor activation. 33, 34 Our results show that PC3-and LNCaP-derived prostasomes are characterized by increases of proteolytic activities, which may degrade the extracellular matrix and control cell adhesion and migration through the reorganization of the actin cytoskeleton. These data are in agreement with the hypothesis that proteolytic degradation is one of the processes responsible for invasion and metastatsis. It is plausible to assume that these differences mirror the different cellular environments of neoplastic cells.
Conclusions
By showing that normal prostasomes have extracellular matrix degrading enzymes and that these enzyme activities are modified in prostate cancer, we think that prostasomes can be tentatively proposed as potential tools for a non-invasive diagnosis of prostate cancer.
